C23H32N2O4
Neat
400.52
-20°C
Room Temperature
Pinoxaden; 243973-20-8; U55GLF9LV9; DTXSID8034823; [8-(2, 6-diethyl-4-methylphenyl)-7-oxo-1, 2, 4, 5-tetrahydropyrazolo[1, 2-d][1, 4, 5]oxadiazepin-9-yl] 2, 2-dimethylpropanoate; DTXCID6014823; CHEBI:83524; 8-(2, 6-diethyl-4-methylphenyl)-1, 2, 4, 5-tetrahydro-7-oxo-7H-pyrazolo(1, 2-d)(1, 4, 5)oxadiazepin-9-yl 2, 2-dimethylpropanoate; 8-(2, 6-DIETHYL-P-TOLYL)-1, 2, 4, 5-TETRAHYDRO-7-OXO-7H-PYRAZOLO(1, 2-D)(1, 4, 5)OXADIAZEPIN-9-YL 2, 2-DIMETHYLPROPIONATE; Propanoic acid, 2, 2-dimethyl-, 8-(2, 6-diethyl-4-methylphenyl)-1, 2, 4, 5-tetrahydro-7-oxo-7H-pyrazolo(1, 2-d)(1, 4, 5)oxadiazepin-9-yl ester; Propanoic acid, 2, 2-dimethyl-, 8-(2, 6-diethyl-4-methylphenyl)-1, 2, 4, 5-tetrahydro-7-oxo-7H-pyrazolo[1, 2-d][1, 4, 5]oxadiazepin-9-yl ester; (8-(2, 6-diethyl-4-methylphenyl)-7-oxo-1, 2, 4, 5-tetrahydropyrazolo(1, 2-d)(1, 4, 5)oxadiazepin-9-yl) 2, 2-dimethylpropanoate; 8-(2, 6-diethyl-p-tolyl)-1, 2, 4, 5-tetrahydro-7-oxo-7H-pyrazolo[1, 2-d][1, 4, 5]oxadiazepin-9-yl 2, 2-dimethylpropionate; RefChem:174366; Pinoxaden [ISO]; Pinoxaden 100 microg/mL in Acetonitrile; UNII-U55GLF9LV9; HSDB 7884; NewAxial; 8-(2, 6-Diethyl-4-methylphenyl)-1, 2, 4, 5-tetrahydro-7-oxo-7H-pyrazolo[1, 2-d][1, 4, 5]oxadiazepin-9-yl 2 and 2-Dimethyl-propanoic Acid Ester;; PINOXADEN [MI]
[8-(2, 6-diethyl-4-methylphenyl)-7-oxo-1, 2, 4, 5-tetrahydropyrazolo[1, 2-d][1, 4, 5]oxadiazepin-9-yl] 2 and 2-dimethylpropanoate
InChI=1S/C23H32N2O4/c1-7-16-13-15(3)14-17(8-2)18(16)19-20(26)24-9-11-28-12-10-25(24)21(19)29-22(27)23(4,5)6/h13-14H,7-12H2,1-6H3